Qualitative versus Quantitative Treatment-by-Subgroup Interaction in Equivalence Studies with Multiple Subgroups

References

• Alosh, M., Fritsch, K., Huque, M., Mahjoob, K., Pennello, G., Rothmann, M., Russek-Cohen, E., Smith, F., Wilson, S., and Yue, L. (2015), “Statistical Considerations on Subgroup Analysis in Clinical Trials,” Statistics in Biopharmaceutical Research, 7, 286–303. DOI: 10.1080/19466315.2015.1077726.
   Web of Science ®Google Scholar
• Alosh, M., Huque, M. F., and Koch, G. G. (2015), “Statistical Perspectives on Subgroup Analysis: Testing for Heterogeneity and Evaluating Error Rate for the Complementary Subgroup,” Journal of Biopharmaceutical Statistics, 25, 1161–1178. DOI: 10.1080/10543406.2014.971169.
   PubMed Web of Science ®Google Scholar
• Bayman, E. Ö., Chaloner, K., and Cowles, M. K. (2010), “Detecting Qualitative Interaction: A Bayesian Approach,” Statistics in Medicine, 29, 455–463.
   PubMed Web of Science ®Google Scholar
• Brookes, S. T., Whitely, E., Egger, M., Smith, G. D., Mulheran, P. A., and Peters, T. J. (2004), “Subgroup Analyses in Randomized Trials: Risks of Subgroup-Specific Analyses: Power and Sample Size for the Interaction Test,” Journal of Clinical Epidemiology, 57, 229–236. DOI: 10.1016/j.jclinepi.2003.08.009.
   PubMed Web of Science ®Google Scholar
• Burstein, H. J. (2005), “The Distinctive Nature of HER2-Positive Breast Cancers,” The New England Journal of Medicine, 353, 1652–1654. DOI: 10.1056/NEJMp058197.
   PubMed Web of Science ®Google Scholar
• FDA Draft Guidance on Medroxyprogesterone Acetate (2013), “Recommended Jun Revised Dec. 2016. Available at https://www.accessdata.fda.gov/drugsatfda_docs/psg/Medroxyprogesterone%20Aceta te_draft_Intramuscular%20susp_RLD%20020246_RC12-16.pdf.
   Google Scholar
• FDA Guidance on Statistical Approaches to Establishing Bioequivalence (2001), Available at https://www.fda.gov/regulatory-information/search-fda-guidance-documents/statistical-approaches-establishing-bioequivalence.
   Google Scholar
• Gail, M., and Simon, R. (1985), “Testing for Qualitative Interactions between Treatment Effects and Patient Subsets,” Biometrics, 41, 361–372. DOI: 10.2307/2530862.
   PubMed Web of Science ®Google Scholar
• Gordon, A. N., Tonda, M., Sun, S., and Rackoff, W. (2004), “Long-Term Survival Advantage for Women Treated with Pegylated Liposomal Doxorubicin Compared with Topotecan in a Phase 3 Randomized Study of Recurrent and Refractory Epithelial Ovarian Cancer,” Gynecologic Oncology, 95, 1–8. DOI: 10.1016/j.ygyno.2004.07.011.
   PubMed Web of Science ®Google Scholar
• Grizzle, J. E. (1965), “The Two-Period Change-Over Design and its Use in Clinical Trials,” Biometrics, 21, 467–480. DOI: 10.2307/2528104.
   PubMed Web of Science ®Google Scholar
• Guidance for Industry E9 Statistical Principles for Clinical Trials (1998), “ICH,” available at https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e9-statistical-principles-clinical-trials.
   Google Scholar
• Kitsche, A. (2014), “Detecting Qualitative Interactions in Clinical Trials with Binary Responses,” Pharmaceutical Statistics, 13, 309–315. DOI: 10.1002/pst.1632.
   PubMed Web of Science ®Google Scholar
• Kitsche, A., and Hothorn, L. A. (2014), “Testing for Qualitative Interaction using Ratios of Treatment Differences,” Statistics in Medicine, 33, 1477–1489. DOI: 10.1002/sim.6048.
   PubMed Web of Science ®Google Scholar
• Koch, G. G. (1997), Discussion of “p-value Adjustments for Subgroup Analyses,” Journal of Biopharmaceutical Statistics, 7, 323–331. DOI: 10.1080/10543409708835190.
   Google Scholar
• Koch, G. G., and Schwartz, T. A. (2014), “An Overview of Statistical Planning to Address Subgroups in Confirmatory Clinical Trials,” Journal of Biopharmaceutical Statistics, 24, 72–93. DOI: 10.1080/10543406.2013.856021.
   PubMed Web of Science ®Google Scholar
• Li, Z., Chuang-Stein, C., and Hoseyni, C. (2007), “The Probability of Observing Negative Subgroup Results when the Treatment Effect is Positive and Homogeneous Across All Subgroups,” Drug Information Journal, 41, 47–56. DOI: 10.1177/009286150704100106.
   Web of Science ®Google Scholar
• Marschner, I. C. (2010), “Regional Differences in Multinational Clinical Trials: Anticipating Chance Variation,” Clinical Trials, 7, 147–156. DOI: 10.1177/1740774510361974.
   PubMed Web of Science ®Google Scholar
• Oulhaj, A., El Ghouch, A., and Holman, R. R. (2019), “Testing for Qualitative Heterogeneity: An Application to Composite Endpoints in Survival Analysis,” Statistical Methods in Medical Research, 28, 151–169. DOI: 10.1177/0962280217717761.
   PubMed Web of Science ®Google Scholar
• Peto, R. (1982), “Statistical Aspects of Cancer Trials,” in Treatment of Cancer, eds. K. E. Hainan, pp. 867–871, London: Chapman and Hall.
   Google Scholar
• Piantadosi, S., and Gail, M. H. (1993), “A comparison of the power of two tests for qualitative interactions,” Statistics in Medicine, 12, 1239–1248. DOI: 10.1002/sim.4780121305.
   PubMed Web of Science ®Google Scholar
• Powers, J. H., Ross, D. B., Lin, D., and Soreth, J. (2004), “Linezolid and Vancomycin for Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: The Subtleties of Subgroup Analyses,” Chest, 126, 314–315. DOI: 10.1378/chest.126.1.314.
   PubMed Web of Science ®Google Scholar
• Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M., Wun, C. C., Davis, B. R., and Braunwald, E. (1996), “The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels,” The New England Journal of Medicine, 335, 1001–1009. DOI: 10.1056/NEJM199610033351401.
   PubMed Web of Science ®Google Scholar
• Wiens, B. L., and Heyse, J. F. (2003), “Testing for Interaction in Studies of Noninferiority,” Journal of Biopharmaceutical Statistics, 13, 103–115. DOI: 10.1081/BIP-120017729.
   PubMedGoogle Scholar
• Yan, X. (2004), “Test for Qualitative Interaction in Equivalence Trials when the Number of Centres is Large,” Statistics in Medicine, 23, 711–722. DOI: 10.1002/sim.1658.
   PubMed Web of Science ®Google Scholar
• Zelterman, D. (1990), “On Tests for Qualitative Interactions,” Statistics & Probability Letters, 10, 59–63.
   Web of Science ®Google Scholar